Valentina Molteni

This inventor holds 39 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in Kinase Inhibitors. Top assignees: Novartis Ag, Irm LLC, Bristol-Myers Squibb Compnay. Active years: 2007-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valentina Molteni. Retrieved from https://idiyas.com/inventor/valentina-molteni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 (Patent Applications = 12)

% Patents Active = 51.3

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 20)

Average Co-Inventor Count = 7.3

ph-index = 8

Forward Citations = 295(Granted Patents)

Company Filing History:

Bristol-Myers Squibb Compnay

patents

4. 1 out of 234

Bristol-Myers Squibb Pharma Company

University of Washington

patents

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2022

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Liver X Receptors

Farnesoid X Receptors

Parasitic Diseases

Bicyclic Compounds

Heterocyclic Compounds

TRK Inhibitors

C-kit Inhibitors

PDF Inhibitors

Compositions

Agonists

Modulators

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11427586 - 1,2,4-oxadiazole derivatives as liver X receptor agonists (2022-08-30),

2. 11384078 - 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases (2022-07-12),

3. 11123348 - Compounds and compositions for the treatment of parasitic diseases (2021-09-21),

4. 11021446 - Compositions and methods for modulating farnesoid X receptors (2021-06-01),

5. 10683271 - Compositions and methods for modulating farnesoid X receptors (2020-06-16),

6. 10596175 - Compounds and compositions for the treatment of parasitic diseases (2020-03-24),

7. 10351576 - Fused tricyclic pyrazole derivatives useful for farnesoid X receptors (2019-07-16),

8. 10085989 - Compounds and compositions for the treatment of parasitic diseases (2018-10-02),

9. 10077240 - Compositions and methods for modulating farnesoid X receptors (2018-09-18),

10. 9751876 - Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension (2017-09-05),

11. 9700559 - Compounds and compositions for the treatment of parasitic diseases (2017-07-11),

12. 9682939 - Compositions and methods for modulating farnesoid X receptors (2017-06-20),

13. 9303034 - Compounds and compositions for the treatment of parasitic diseases (2016-04-05),

14. 9296754 - Compounds and compositions for the treatment of parasitic diseases (2016-03-29),

15. 9233961 - Compounds and compositions for the treatment of parasitic diseases (2016-01-12),

Title: The Innovative Journey of Valentina Molteni

Introduction: Valentina Molteni, a pioneering inventor based in San Diego, CA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Valentina Molteni's latest patents include a revolutionary wearable device that tracks health metrics in real-time and a cutting-edge software application designed to streamline communication in remote work settings.

Career Highlights: With a background in engineering and a passion for creating solutions to everyday challenges, Valentina Molteni has led successful projects in various tech companies, earning her a reputation as a visionary in the industry.

Collaborations: Throughout her career, Valentina Molteni has collaborated with top researchers, engineers, and designers to bring her ideas to life, resulting in the development of award-winning products that have transformed the way we interact with technology.

Conclusion: Valentina Molteni's relentless pursuit of innovation and her commitment to pushing the boundaries of technology continue to inspire the next generation of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.